Iovance Biotherapeutics, Inc.
Real-time prices from Yahoo Finance's public feed. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Latest news
All IOVA news ›Stoke Therapeutics, Inc. (STOK)
Stock Price, News, Quote & History Yahoo! Finance Canada Oops, something went wrong Stoke Therapeutics, Inc. (STOK) Stoke Therapeutics, Inc. Overview Biotechnology / Healthcare Stoke Therapeutics, Inc. engages in the development of…
Why DaVita HealthCare (DVA) Outpaced the Stock Market Today
DaVita HealthCare (DVA) ended the recent trading session at $179.25, demonstrating a +1.26% change from the preceding day's closing price. The stock outperformed the S&P 500, which registered a daily gain of 0.6%. On the other hand, the…
Direxion Daily INTC Bull 2X ETF (LINT)
Stock Price, News, Quote & History Yahoo! Finance Canada Oops, something went wrong Direxion Daily INTC Bull 2X ETF (LINT) Direxion Daily INTC Bull 2X ETF Overview Direxion Funds / Trading--Leveraged Equity The fund, under normal…
Teva, Already Up 26% This Year, Surges Again On First-Of-Its-Kind Approval
Allison Gatlin covers biotechnology, pharmaceuticals and medical technology. She also oversees coverage of top-performing companies for Investor's Business Daily's The New America page. Allison has worked for Investor's Business Daily…
TEVA Stock Hits Fresh 52-Week High As FDA Approves Monthly Schizophrenia Shot
NYSE-listed shares of Teva Pharmaceutical Industries (TEVA) rallied on Friday, touching fresh 52-week highs, after the company won U.S. FDA approval for a once-monthly schizophrenia injection, extending a strong year for the stock. TEVA…
Immunitybio Inc Stock (IBRX) Moved Up by 8.17% on Oct 9: Drivers Behind the Movement
TradingKey Immunitybio Inc Stock (IBRX) Moved Up by 8.17% on Oct 9: Drivers Behind the Movement What is driving Immunitybio Inc (IBRX)’s stock price up today? ImmunityBio (IBRX) experienced strong upward price momentum accompanied by…
Zacks Initiates Coverage of SSi With Neutral Recommendation
Stronger product adoption is also translating into revenue growth. Revenues for the first six months of 2026 increased to $25 million from $15.1 million a year earlier, supported by higher system and instrument sales. Gross profit rose to…
IBRX Stock Extends Rally As Traders Bet On Oncology Momentum
ImmunityBio Inc. surges as pivotal clinical progress drives bullish sentiment, and stocks have been trading up by 7.82 percent. Key Takeaways Shares are up 12.4%, or $1.15, with ImmunityBio trading around $10.43 after a string of…
AiBizEngine Review The Main Benefits and Risks Explained.png
The Arab Tribune AiBizEngine Review The Main Benefits and Risks Explained AiBizEngine Review: Turn One Product Into 50+ Assets & Multiple Income Streams There was a problem reporting this. Keep it Clean. Please avoid obscene, vulgar, lewd,…
AngioDynamics anticipates $336M to $341M FY2027 net sales as CEO transition takes effect November 2
AngioDynamics (ANGO) Q1 FY2027 earnings call recap: revenue +7%, NanoKnife +29%, CEO transition, FY27 guidance and margin outlook. Earnings Call Insights: AngioDynamics (ANGO) Q1 fiscal 2027 - "Our Board has completed a comprehensive…
From articles in the 4Search news index.
In the news
Mentioned with
People in the coverage
Themes
Most coverage from
-
themarketsdaily.com10
-
defenseworld.net9
-
tradingview.com7
-
ca.finance.yahoo.com5
-
gurufocus.com4
Measured across the 4Buffalo news index. Headline tone is a simple word-based reading of the latest 79 headlines, not a forecast.